Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 21 (5%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOSARTAN | 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82935 |
| LOSARTAN | 50MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82938 |
| LOSARTAN | 25MG | TABLET | Resolved | 2019-07-25 | 2021-05-06 | 89940 |
| LOSARTAN | 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145528 |
| LOSARTAN | 25MG | TABLET | Actual shortage | 2021-09-13 | 2021-09-14 | 145531 |
| LOSARTAN | 50MG | TABLET | Actual shortage | 2021-09-13 | 2024-05-28 | 145534 |
| LOSARTAN | 100MG | TABLET | Actual shortage | 2021-09-20 | 2024-04-23 | 145888 |
| LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67312 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67315 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-11-21 | 2021-05-06 | 67321 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82941 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145537 |
| LOSARTAN/HCTZ | 25MG 100MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145541 |
| LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2021-09-13 | 2024-05-29 | 145547 |
| LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Anticipated shortage | 2024-05-28 | 2024-05-28 | 229003 |
| LOVASTATIN | 20MG | TABLET | Resolved | 2019-06-27 | 2019-07-26 | 87568 |
| LOVASTATIN | 40MG | TABLET | Resolved | 2020-01-21 | 2024-03-02 | 103759 |
| LOVASTATIN | 20MG | TABLET | Resolved | 2020-01-21 | 2024-03-02 | 103762 |
| MELOXICAM | 7.5MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85269 |
| MELOXICAM | 15MG | TABLET | Resolved | 2019-05-30 | 2022-08-30 | 85272 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |